Istradefylline
Selective A2A antagonist used as adjunctive therapy for off-time.
State of the art
No update yet for Istradefylline. An update is a standalone state-of-the-art for the topic — what someone with Parkinson's needs to know about where this approach stands today.
No reader summaries on this topic yet.